RISE’s Product Portfolio Grows with Intimacy Oral Spray,Topical Muscle Recovery Products and Oral-Dose Tablets Cannabis Investing News
Algernon Pharmaceuticals Announces Reduction of Key Secondary Marker of Fibrosis in Pre-Clinical NASH Study Pharmaceutical Investing
MediPharm Labs Announces DTC Eligibility, Increasing Accessibility for US Investors Cannabis Investing News
PreveCeutical Files Application to Human Ethics Committee to Acquire Human Tissue for the Final Phase of the Sol-Gel Program Biotech Investing
Life Science Big News Roundup: Bion Announces Positive Results from 3G Simulation and Testing; PreveCeutical Announces Further Results from its Preliminary Screening of Peptides Derived from Blue Scorpion Venom Life Science Investing News
Albireo Announces FDA Clearance of IND to Commence Phase 2 Trial of Elobixibat Pharmaceutical Investing
Radiopharm Theranostics and Cyclotek Sign Clinical Supply Agreement for ¹?¹Tb-KLK3-mAb Phase I Clinical Trial in Australia
